Giorgio Ballardini

5.2k total citations · 1 hit paper
93 papers, 3.3k citations indexed

About

Giorgio Ballardini is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Giorgio Ballardini has authored 93 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 67 papers in Hepatology, 52 papers in Epidemiology and 15 papers in Surgery. Recurrent topics in Giorgio Ballardini's work include Liver Disease Diagnosis and Treatment (45 papers), Hepatitis C virus research (29 papers) and Liver Diseases and Immunity (23 papers). Giorgio Ballardini is often cited by papers focused on Liver Disease Diagnosis and Treatment (45 papers), Hepatitis C virus research (29 papers) and Liver Diseases and Immunity (23 papers). Giorgio Ballardini collaborates with scholars based in Italy, United Kingdom and France. Giorgio Ballardini's co-authors include Francesco B. Bianchi, E Pisi, Daniela Zauli, Marco Lenzi, F. Cassani, Rita Mirakian, Deborah Doniach, GianFranco Bottazzo, Alberto Grassi and Fabrizio Giostra and has published in prestigious journals such as The Lancet, Journal of Clinical Investigation and SHILAP Revista de lepidopterología.

In The Last Decade

Giorgio Ballardini

90 papers receiving 3.2k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

ABERRANT EXPRESSION OF HLA-DR ANTIGENS ON BILEDUCT EPITHELIUM IN PRIMARY BILIARY CIRRHOSIS: RELEVANCE TO PATHOGENESIS

1984 380 citations Giorgio Ballardini, Rita Mirakian et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Giorgio Ballardini Italy	34	2.2k	1.6k	760	499	361	93	3.3k
Carlo Fabris Italy	29	1.5k 0.7×	1.7k 1.0×	478 0.6×	259 0.5×	299 0.8×	160	3.0k
Elie‐Serge Zafrani France	26	1.4k 0.6×	1.0k 0.6×	586 0.8×	224 0.4×	342 0.9×	55	2.8k
Edward L. Krawitt United States	27	3.8k 1.7×	3.4k 2.1×	1.2k 1.6×	794 1.6×	264 0.7×	63	4.8k
Johannes Herkel Germany	32	1.9k 0.8×	1.6k 1.0×	566 0.7×	428 0.9×	503 1.4×	73	3.5k
Harry L.A. Janssen Netherlands	37	2.0k 0.9×	2.1k 1.3×	655 0.9×	232 0.5×	812 2.2×	112	3.9k
Yun Ma United Kingdom	37	3.0k 1.4×	2.5k 1.5×	884 1.2×	768 1.5×	337 0.9×	73	4.3k
Luisa Garcı́a-Buey Spain	24	1.4k 0.6×	1.3k 0.8×	188 0.2×	278 0.6×	308 0.9×	70	2.3k
Julia C. Iezzoni United States	22	945 0.4×	1.9k 1.1×	578 0.8×	157 0.3×	515 1.4×	43	2.8k
Hirayuki Enomoto Japan	34	1.3k 0.6×	1.3k 0.8×	372 0.5×	561 1.1×	1.6k 4.4×	181	4.0k
Seong Gyu Hwang South Korea	33	1.9k 0.9×	1.8k 1.1×	832 1.1×	163 0.3×	865 2.4×	134	3.8k

Countries citing papers authored by Giorgio Ballardini

Since Specialization

Citations

This map shows the geographic impact of Giorgio Ballardini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Giorgio Ballardini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Giorgio Ballardini more than expected).

Fields of papers citing papers by Giorgio Ballardini

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Giorgio Ballardini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Giorgio Ballardini. The network helps show where Giorgio Ballardini may publish in the future.

Co-authorship network of co-authors of Giorgio Ballardini

This figure shows the co-authorship network connecting the top 25 collaborators of Giorgio Ballardini. A scholar is included among the top collaborators of Giorgio Ballardini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Giorgio Ballardini. Giorgio Ballardini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Foschi, Francesco Giuseppe, Alberto Borghi, Alberto Grassi, et al.. (2021). Model of Care for Microelimination of Hepatitis C Virus Infection among People Who Inject Drugs. Journal of Clinical Medicine. 10(17). 4001–4001. 4 indexed citations

Cortellini, Gabriele, et al.. (2018). Effective Ibuprofen Desensitization in a Patient with Myopericarditis. Pharmacology. 103(3-4). 111–113.

Cortellini, Gabriele, et al.. (2018). Effective Desensitization to Tocilizumab in Delayed Hypersensitivity Reaction. Pharmacology. 102(1-2). 114–116. 10 indexed citations

Ferri, S., Luigi Muratori, Chiara Quarneti, et al.. (2009). Clinical features and effect of antiviral therapy on anti-liver/kidney microsomal antibody type 1 positive chronic hepatitis C. Journal of Hepatology. 50(6). 1093–1101. 18 indexed citations

Piscaglia, Fabio, Valeria Camaggi, Matteo Ravaioli, et al.. (2007). A New Priority Policy for Patients with Hepatocellular Carcinoma Awaiting Liver Transplantation Within the Model for End-Stage Liver Disease System. Liver Transplantation. 13(6). 857–866. 35 indexed citations

Grassi, Alberto, Chiara Quarneti, Matteo Ravaioli, et al.. (2006). Detection of Hcv Antigens in Liver Graft: Relevance To the Management of Recurrent Post-Liver Transplant Hepatitis C. Liver Transplantation. 12(11). 1673–1681. 12 indexed citations

Grassi, Alberto, Matteo Ravaioli, Gian Luca Grazi, et al.. (2004). Detection of recipient’s cells in liver graft using antibodies to mismatched HLA class I antigens. Liver Transplantation. 10(11). 1406–1414. 8 indexed citations

Spirlı̀, Carlo, Luca Fabris, Elena Duner, et al.. (2003). Cytokine-stimulated nitric oxide production inhibits adenylyl cyclase and cAMP-dependent secretion in cholangiocytes. Gastroenterology. 124(3). 737–753. 96 indexed citations

Rullier, Anne, Pascale Trimoulet, Pierre–Henri Bernard, et al.. (2001). Immunohistochemical (IHC) demonstration of HCV recurrence after liver transplantation. Journal of Hepatology. 34. 49–49. 1 indexed citations

10.

Marangoni, Antonella, Rita Aldini, Vittorio Sambri, et al.. (2000). Uptake and Killing of Leptospira interrogans and Borrelia burgdorferi , Spirochetes Pathogenic to Humans, by Reticuloendothelial Cells in Perfused Rat Liver. Infection and Immunity. 68(9). 5408–5411. 15 indexed citations

11.

Zauli, Daniela, Sabrina Ghetti, Alberto Grassi, et al.. (1997). Anti-neutrophil cytoplasmic antibodies in type 1 and 2 autoimmune hepatitis. Hepatology. 25(5). 1105–1107. 100 indexed citations

12.

Cassani, F., Paolo Valentini, Michela Cataleta, et al.. (1997). Ultrasound-detected abdominal lymphadenopathy in chronic hepatitis C: high frequency and relationship with viremia. Journal of Hepatology. 26(3). 479–483. 40 indexed citations

13.

Ballardini, Giorgio, Paolo Groff, Fabrizio Giostra, et al.. (1995). Hepatocellular codistribution of c100, c33, c22, and NS5 hepatitis C virus antigens detected by using immunopurified polyclonal spontaneous human antibodies. Hepatology. 21(3). 730–734. 33 indexed citations

14.

Lenzi, Marco, Luigi Muratori, Michela Cataleta, et al.. (1995). Liver cytosolic 1 antigen-antibody system in type 2 autoimmune hepatitis and hepatitis C virus infection.. Gut. 36(5). 749–754. 63 indexed citations

15.

Ballardini, Giorgio. (1995). Rare coexpression of tissue HBV and HCV antigens in chronic liver disease: Evidence for viral interference?. Hepatology. 22(4). A265–A265. 1 indexed citations

16.

Ballardini, Giorgio, Paolo Groff, Fabrizio Giostra, et al.. (1994). Hepatocellular Expression of HLA-A, B, C Molecules Predicts Primary Response to Interferon in Patients with Chronic Hepatitis C. American Journal of Clinical Pathology. 102(6). 746–751. 11 indexed citations

17.

Ma, Yan, Marco Lenzi, Joop Gäken, et al.. (1992). 32 THE TARGET ANTIGEN OF LIVER KIDNEY MICROSOMAL ANTIBODY IS DIFFERENT IN TYPE II AUTOIMMUNE CHRONIC ACTIVE HEPATITIS AND CHRONIC HEPATITIS C VIRUS INFECTION. Journal of Pediatric Gastroenterology and Nutrition. 15(3). 346–346. 5 indexed citations

18.

Lenzi, Marco, M. Baldi, C Lavarini, et al.. (1990). HCV infection in LKMI autoimmune hepatitis (AH) is confirmed by recombinant immunoblotting assay (RIBA). Journal of Hepatology. 11. S40–S40. 1 indexed citations

19.

Ballardini, Giorgio, Francesco B. Bianchi, Rita Mirakian, et al.. (1987). HLA-A,B,C, HLA-D/DR and HLA-D/DQ expression on unfixed liver biopsy sections from patients with chronic liver disease.. PubMed. 70(1). 35–46. 42 indexed citations

20.

Ballardini, Giorgio, M Fallani, V. Vasi, et al.. (1985). Sequential behaviour of extracellular matrix glycoproteins in an experimental model of hepatic fibrosis. Virchows Archiv B Cell Pathology Including Molecular Pathology. 49(1). 317–324. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact